Genetic Predictors of Postpartum Depression Uncovered
The alteration of the TTC9B and HP1BP3 genes, detected by a blood test during pregnancy, predicted the onset of postpartum depression with 85% accuracy in a small study.
Molecular Trigger for Alzheimer’s Disease Identified
A new study has pinpointed a catalytic trigger for the onset of Alzheimer’s disease. The findings could play a central role in the diagnostics and new drug development for neurodegenerative diseases.
Study Identifies New Approach to Improving Treatments for MS and Other Conditions
Researchers discovered a novel molecular target for the design of drugs which could be safer and more effective for multiple sclerosis, as well as other disorders associated with the loss of white matter in the brain.
Fishing for Memories
Observing whole-brain activity in live zebrafish, researchers have discovered how information stored as long-term memory in the cerebral cortex is processed to guide behavioral choices.
Physicist’s Tool has Potential for Brain Mapping
Researchers have developed a fiber-optic, two-photon optogenetic simulator which can be used to stimulate a light sensitive protein introduced into neurons and living cells in the brain. The researchers suggest this technology would be a useful tool for the BRAIN mapping initiative.
Brain Rewires Itself After Damage or Injury
When the hippocampus, an area of the brain associated with memory and learning, is damaged, the prefrontal cortex takes over. This demonstration of neuroplasticity could give rise to new treatment options for Alzheimer’s disease and other conditions associated with damage to the brain.
Skin Cancer May Be Linked to Lower Risk of Alzheimer’s Disease
According to new research, people who had skin cancer were almost 80% less likely to later develop Alzheimer’s disease.
Brain-Imaging Study Links Cannabinoid Receptors to Post-Traumatic Stress Disorder
Researchers discover a connection between the quantity of CB1 cannabinoid receptors in the brain and PTSD.
New Drug Enhances Radiation Treatment for Brain Cancer in Preclinical Studies
A new drug could help increase the effectiveness of radiation therapy for patients with glioblastoma multiforme, the most deadly form of brain cancer. The ATM kinase inhibitor, in combination with radiation therapy, helped significantly extend survival rates in mouse models of GBM.
